Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New HOD coming imo
Fannie Mae Appoints New Chairman
DOW JONES & COMPANY, INC. 11:48 AM ET 2/25/2014
Symbol Last Price Change
FNMA 3.69down +0.11 (+3.07%)
QUOTES AS OF 12:46:22 PM ET 02/25/2014
Philip A. Laskawy, who took over as Fannie Mae's(FNMA) chairman at the height of the financial crisis, will retire March 31, as he will reach his mandatory retirement age, the government-controlled mortgage-finance enterprise said in a filing Tuesday.
Egbert Perry, a director on the board since 2008, will replace Mr. Laskawy, Fannie Mae(FNMA) said.
Previously, Mr. Perry served as a director of the Federal Reserve Bank of Atlanta from 2002 to 2008. He has about 35 years of experience in the real-estate industry, Fannie Mae(FNMA) said.
Mr. Laskawy, who is 72 years old, took over as chairman of Fannie Mae(FNMA) in September 2008, just as the financial crisis and housing bust was reaching its peak in the U.S.
Fannie has borrowed $116 billion from the U.S. Treasury as part of the government's bailout of the financial industry. Last week, Fannie Mae(FNMA) said it would pay $7.2 billion to the Treasury next month, increasing the total dividends that Fannie and the smaller Freddie Mac have paid the government to about $192.5 billion. That amount exceeds the $187.5 billion in bailout money that they received.
Shares of Fannie Mae(FNMA) rose 2.5% to $3.67 in recent trading.
Write to Michael Calia at michael.calia@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
02-25-141248ET
Copyright (c) 2014 Dow Jones & Company, Inc.
did anyone see the 1.3 mil that was on the BID briefly. someone or something wants a lot of shares
‘Attractive Investment’
“The issuer’s common stock is undervalued and is an attractive investment,” Pershing Square said, adding that it may seek “discussions with management, the board, other stockholders of the issuer, representatives of the federal government, and other relevant parties.”
Fannie Mae’s 8.25 percent junior preferred shares, which have a par value of $25, rose 1.3 percent to $9.93 today. That’s the highest since 2008, when Fannie Mae and Freddie Mac were seized by the government.
Berkowitz and investors including hedge fund-firms Paulson & Co. and Perry Capital LLC bought the shares in a wager that the U.S. government would keep the mortgage companies alive. Fairholme’s proposal would raise at least $17.3 billion in additional funds from preferred holders and through a rights offering, Fairholme said
a reverse split always screws the early investors. you better hope that doesn't happen. would not be smart by the company. Yes price goes up but usually drops back down over time. I have never seen it work to the advantage of early investors. I am sure someone will give some remote example of where it was good but we better hope this does not happen. Not even sure why we are talking about this or uplisting to Nasdaq. I hope it just steadily churns upward.
No problem. Thanks for all the valuable information on Titan. I learned in sales a long time ago not to mention the competitors name too much. Makes your customer think you are worried about them! I am not the least bit concerned about that other company. Thanks for the words
Nice Job!
Thank you for sharing that article!
I have no idea. We talk about it more on this site than they do on theirs. seems a bit odd to me. im not interested and apparently not many other people are interested either. I wont be commenting on this other fly by night company any more!
We have more discussion about TRXC on our site than they do on theirs. Something wrong with this. unbelievable
it will never happen with that company. good luck! Post on the TRXC board
Hate to tell you but reverse splits are never good. don't even respond to this message I have seen this time and time before. good luck
Maybe so. Hopefully we hear an update soon. I feel confident something will come out now that we are behind the offering
lol. not normally. in the past we seemed to have news out pretty regularly. I'm hoping it anytime soon. maybe they wanted to get the offering behind them and we will see an update soon.
Stratasys Appoints BIOLASE(R) as a Distributor of Its Design Series 3-D Printers
Print
Alert
Biolase, Inc. (MM) (NASDAQ:BIOL)
Intraday Stock Chart
Today : Thursday 20 February 2014
Click Here for more Biolase, Inc. (MM) Charts. Stratasys Appoints BIOLASE(R) as a Distributor of Its Design Series 3-D Printers
First Distributor Focused on In-Office, Chair-Side Market
3-D Printer on Display at 149th Chicago Dental Society Midwinter Meeting
IRVINE, CA--(Marketwired - Feb 20, 2014) - BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase®, and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill™ CAD/CAM systems for dentistry, today announced that it has entered into a Reseller Agreement (the "Agreement") with Stratasys, Inc. (NASDAQ: SSYS).
Pursuant to the terms of the Agreement, BIOLASE will become a distributor of Stratasys' Objet30 OrthoDesk and a number of Design Series High End 3-D printers. The Objet30 OrthoDesk combines accurate and precise 3-D printing technology with a small footprint. It is easy to use, and includes specialized dental printing materials in convenient sealed cartridges. Dentists can fabricate stone models, orthodontic appliances, delivery and positioning trays, models for clear aligners, retainers and surgical guides on their desktop.
Federico Pignatelli, Chairman and CEO of BIOLASE, stated, "We are thrilled to be chosen as the first distributor of Stratasys' dental 3-D printing products for the in-office, chair-side market. We believe that 3-D printing will be a revolutionary factor in dental restoration in the new digital era of dentistry. By combining high-end digital imaging, first in class laser tissue management, intra-oral scanning, CAD/CAM design, chair-side milling, and 3-D printing, dental offices can accurately and rapidly produce a wide range of restorations and appliances. We believe that Stratasys will be the perfect long-term partner for BIOLASE as more and more dental offices recognize the excellent return on investment a digital office provides, as well as the increased convenience and benefits high-tech products provide their patients."
Craig Perry, Vice President of Vertical Sales-Americas of Stratasys, stated, "Our Objet30 Series is the world's most versatile desktop 3-D printer. It is compact, affordable, and easy to use. With patented, industry-leading Polyjet 3-D printing technology, it offers all of the advantages of a 3-D printer, in a package just right for a dental office."
A Stratasys Objet30 OrthoDesk will be integrated into BIOLASE's Total Technology Solution display in Booth 4445 at the 149th Chicago Dental Society Midwinter Meeting. The Midwinter Meeting will be held at the McCormick Place West building, located at 2301 S. Indiana Ave., Chicago, Illinois, from Thursday through Saturday, February 20 - 22, 2014.
About Stratasys
Stratasys Ltd., headquartered in Minneapolis, Minn. and Rehovot, Israel, manufactures 3D printers and materials for prototyping and production. The company's patented FDM® and PolyJet® 3-D printing technologies produce prototypes and manufactured goods directly from 3-D CAD files or other 3-D content. Systems include 3-D printers for idea development, prototyping and direct digital manufacturing. Stratasys subsidiaries include MakerBot and Solidscape and the company operates the RedEye digital-manufacturing service. Stratasys has more than 1,700 employees, holds over 500 granted or pending additive manufacturing patents globally, and has received more than 20 awards for its technology and leadership.
Online at: stratasys.com or blog.stratasys.com.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment and CAD/CAM intraoral scanners and in-office milling machines; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's proprietary laser products incorporate approximately 300 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 24,800 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc and YouTube at www.youtube.com/biolasevideos.
BIOLASE®, WaterLase®, MDX™, MD Turbo™, EPIC™, iLase™, GALAXY BioMill™, are registered trademarks or trademarks of BIOLASE, Inc.
For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700
we need some update badly on the tissue testing. its over due.
Opening higher!
Nice news out!
I called him out a long time ago and said I would not respond to any messages pumping another stock on this board. we all know what his agenda is. Thanks for keeping messages on this board related to the Titan product!
interesting watching all the bantering back and forth. maybe its the valentines day curse. lol
so why is the selling expected?
not looking good. need news
I don't think any company would buy another company without the product approved. does not make sense. that is down the line a ways. what we need is an update on tissue testing. How is it going etc? Need an update badly
does anyone think its interesting that the stock options granted in 2012 had a strike price of 1.38?
Someone help me understand why the volume has completely fallen off. what does what happened last week have to do with people who want to buy and sell. companies dilute all the time and the volume keeps going.
Thank you
how do you short a pink sheet stock?
people getting tired hitting the ask and it never changes. whats up with that.
it appears most of us know or have connections with people in the medical field. I am in the medical field and I don't believe we are investing in blind luck with this company. too many medical professionals know about this company and are invested. nice job picking up those shares! one day we will look back on this and say wow we were right! Good luck!
it always cracks me up that when a stock drops some all these naysayers come out of hiding and say sell, sell, sell! do you think stocks go up everyday? Think back a month or so when Zuckerberg sold a bunch of his shares in facebook and the stock took a beating. I guess you should have bought on that dip right? Titan will go up over the long haul and anyone sitting on the sidelines should get in IMO.
my strategy is to not look at it for a year then open my account and see how much money I have. when I look at it every day I tend to make stupid mistakes!
800,000 shares have traded in Canada. I believe the price will stay around 1.27 until feb 19 or so. I feel good that this is going up after that as news is released.
if you think the price is going to go up over time just buy the stock. The stock is much more liquid and I am convinced this will be going up over time.
if you go back and read earlier posts the process has been explained over and over.
30,000 buy
these prices are cheap. better get it while you can. could have got 1.14 on Friday. I only see this going up
good morning everyone. hoping for a good day!
You guys keep asking the same questions over and over. Lol
why would it be held up this long? what would be the reason